Navigation Links
Invitation: PROSTVAC(TM) Wrap up
Date:5/27/2009

KVISTGAARD, Denmark, May 27 /PRNewswire-FirstCall/ -- Following the presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine candidate for the treatment of advanced prostate cancer, Bavarian Nordic will be hosting a Q&A session at the ASCO Annual Meeting.

Time: Sunday, May 31st 2009 from 09 AM EDT to 10 AM EDT.

Location: Rosen Centre Hotel, 9840 International Drive, Orlando, Florida 32819

At the Q&A session, Bavarian Nordic's PROSTVAC(TM) team and President & CEO, Anders Hedegaard will attend.

The Q&A session follows the presentation of final Phase 2 data with PROSTVAC(TM) at the 2009 ASCO Annual Meeting. The presentation will take place on May 30, 2009 at 5:00 PM EDT and will be held by Philip Kantoff, MD, Professor of Medicine, Harvard Medical School, and the Dana-Farber Cancer Institute who is also principal investigator in the study.

Looking forward to seeing you there!

About PROSTVAC(TM)

PROSTVAC(TM) is a therapeutic vaccine moving into late stage clinical development. PROSTVAC(TM) has the potential to extend survival with improved quality of life in patients with advanced prostate cancer.

About Bavarian Nordic

Bavarian Nordic A/S is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more information please visit http://www.bavarian-nordic.com


'/>"/>
SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured by ... and manufacturing combine to progress molecular radiotherapy imaging. ... are unable to accurately quantify the radiation absorbed by those ... the success of this radiotherapy treatment has been available — ... ...
(Date:7/1/2017)... 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available ... call. The live audio webcast can be accessed ... It will be archived for replay following the conference call. ...
Breaking Medicine Technology:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to communities in the greater Birmingham area, is ... provide resources to underprivileged young people in the region. , The Chris Hammond ...
(Date:7/21/2017)... ... July 21, 2017 , ... Bernard R. Bach, Jr., MD, orthopaedic surgeon ... American Orthopaedic Society of Sports Medicine (AOSSM) , received the 2017 Robert E. Leach ... in Toronto, Canada. This prestigious award is given annually to honor those who have ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to regulate their ... Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help with ... Monday, July 21st. , The kit uses colorful, engaging and educational illustrations and ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... into why concussion rates are on the rise, say researchers presenting their work ... in Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change ...
(Date:7/20/2017)... ... 2017 , ... Coats Rose, P.C. , a business ... expansion to the Midwest with the establishment of the firm’s new Cincinnati office. ... of counsels, John Peck and Robert Bruns, will establish and anchor Coats Rose’s ...
Breaking Medicine News(10 mins):